ResearcherHarvard UniversityActive in the last 2 years
Pushpamali De Silva
Matched on ORCID iD 0000-0002-0747-5637; OpenAlex author ID A5062062627. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 4
- Markers of immune activation and immunotherapy responsiveness are increased in 3D Pancreatic cancer organoids when primed with photodynamic- and chemo-therapy. Co-author DOI 10.1016/j.tranon.2026.102716↗
- Photodynamic priming enhances anti-PD1 therapy responses in patient-derived pancreatic cancer organoid immune cocultures. Co-author DOI 10.3389/fimmu.2026.1805948↗
- Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model. Co-author DOI 10.1016/j.jphotobiol.2025.113126↗
- Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D in vitro heterocellular model of pancre… Co-author DOI 10.1515/nanoph-2021-0304↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tayyaba Hasan · 4 shared papers, 2021–2026 · strength 0.99
- Paper Markers of immune activation and immunotherapy responsiveness are increased in 3D Pancreatic cancer organoids when prim… DOI 10.1016/j.tranon.2026.102716↗
- Paper Photodynamic priming enhances anti-PD1 therapy responses in patient-derived pancreatic cancer organoid immune coculture… DOI 10.3389/fimmu.2026.1805948↗
- Paper Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model. DOI 10.1016/j.jphotobiol.2025.113126↗
- Edward V. Maytin · 3 shared papers, 2021–2026 · strength 0.64
- Paper Photodynamic priming enhances anti-PD1 therapy responses in patient-derived pancreatic cancer organoid immune coculture… DOI 10.3389/fimmu.2026.1805948↗
- Paper Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model. DOI 10.1016/j.jphotobiol.2025.113126↗
- Paper Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D… DOI 10.1515/nanoph-2021-0304↗
- Mohammad Ahsan Saad · 2 shared papers, 2025–2026 · strength 0.57
- Paper Markers of immune activation and immunotherapy responsiveness are increased in 3D Pancreatic cancer organoids when prim… DOI 10.1016/j.tranon.2026.102716↗
- Paper Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model. DOI 10.1016/j.jphotobiol.2025.113126↗
- Vinay Chandrasekhara · 2 shared papers, 2025–2026 · strength 0.48
- Paper Photodynamic priming enhances anti-PD1 therapy responses in patient-derived pancreatic cancer organoid immune coculture… DOI 10.3389/fimmu.2026.1805948↗
- Paper Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model. DOI 10.1016/j.jphotobiol.2025.113126↗
- Kenneth K. Wang MD · 2 shared papers, 2021–2025 · strength 0.38
- Paper Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model. DOI 10.1016/j.jphotobiol.2025.113126↗
- Paper Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D… DOI 10.1515/nanoph-2021-0304↗
- Brian William Pogue · 2 shared papers, 2021–2025 · strength 0.38
- Paper Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model. DOI 10.1016/j.jphotobiol.2025.113126↗
- Paper Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D… DOI 10.1515/nanoph-2021-0304↗
- Fernanda V. Cabral · 1 shared paper, 2026 · strength 0.36
- Andrew Scott Liss · 1 shared paper, 2026 · strength 0.26
- Bryan Quilty Spring · 1 shared paper, 2025 · strength 0.22
- Shazia Bano · 1 shared paper, 2021 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.